Protara Therapeutics, Inc. Other Non-Current Assets
Protara Therapeutics, Inc. (TARA) had Other Non-Current Assets of $74.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-11
- 2026-06-30: Other Assets, Noncurrent $74.00K.
- 2026-03-31: Other Assets, Noncurrent $76.00K.
- 2025-12-31: Other Assets, Noncurrent $20.00K.
- 2025-09-30: Other Assets, Noncurrent $21.00K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $74.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $76.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $20.00K 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $21.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $29.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $35.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $27.00K 10-K · filed 2026-03-10 | |
| 2024-09-30 | $33.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $19.00K 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $31.00K 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $11.00K 10-K · filed 2025-03-05 | |
| 2023-09-30 | $2.94M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $2.88M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $586.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $16.00K 10-K · filed 2024-03-13 | $644.00K 10-K · filed 2023-03-08 |
| 2022-09-30 | $734.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $811.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $787.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $865.00K 10-K · filed 2023-03-08 | |
| 2021-09-30 | $946.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.02M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $2.13M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $1.16M 10-K · filed 2022-03-09 | $2.22M 10-K · filed 2021-03-11 |
| 2020-09-30 | $1.66M 10-Q · filed 2020-11-12 | |
| 2018-09-30 | $100.00K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $100.00K 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $240.00K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $218.00K 10-K · filed 2019-03-13 | $240.00K 10-K · filed 2018-03-14 |
| 2017-09-30 | $300.00K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $300.00K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $299.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $393.00K 10-K · filed 2018-03-14 | |
| 2016-09-30 | $276.00K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $383.00K 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $693.00K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $706.00K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $686.00K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $685.00K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $114.00K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $114.00K 10-K · filed 2016-03-14 | |
| 2014-09-30 | $2.17M 10-Q · filed 2014-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |